Youngsters suffering from medulloblastomas, the most common malignant brain tumor in children, now have a higher survival rate than ever before – 80 percent, up from 50 percent just 10 years ago. That is due in part to dedicated physicians like Avinash L. Mohan, M.D., a pediatric neurosurgeon at the Maria Fareri Children’s Hospital and new member of the Westchester Brain Tumor Program team.
Ever since Dr. Mohan cared for his first medulloblastoma patient ten years ago during hew New York medical College residency at Maria Fareri, he has dedicated himself to treating the disease. He was deeply involved in research on the subject while a fellow at the NYU School of Medicine and then at Chicago’s Children’s Memorial Hospital, before returning to Maria Fareri in 2008. (more…)
The Westchester Brain Tumor Program is now offering Tumor Transfer Fields (TTFields) therapy, a non-invasive alternative to chemotherapy for patients with recurrent glioblastoma multiforme. TTFields therapy uses alternating electrical fields to slow and reverse tumor growth by disrupting the uncontrolled division of cancer cells. WBTP is using the NovoTTF (TM) system from Novocure. (more…)
Westchester Brain Tumor Program Now Offers Molecular Testing To Identify Best Treatment Options for Brain Cancer PatientsJanuary 18th, 2013 | Posted by in News - (0 Comments)
Patients being treated for complex brain tumors at the Westchester Brain Tumor Program now have the potentially life-extending option of cutting-edge testing that profiles individual tumors at the molecular level.
The molecular profiling identifies biomarkers specific to an individual patient’s tumor—including a tumor’s unique signature for DNA, cell surface receptors, and proteins—and pinpoints the best treatment options. (more…)
Julie C. Choi, M.D., the primary radiation oncologist for the Westchester Brain Tumor Program, believes that cancer patients are unlike any other patients. “it’s a disease that changes people. Cancer patients embrace life; they touch you in a special way,” she explains.
So early in her career, Dr. Choi decided to switch from Internal Medicine, in which she is board certified, to radiation oncology. Today, she is affiliated with the Departments of Radiation Oncology at Northern Westchester Hospital and New Milford Hospital, and serves as the primary radiation oncologist for the Westchester Brain Tumor Program.
Dr. Choi has extensive experience in treating brain tumors, both malignant and benign.
While an attending at Columbia Presbyterian Medical Center in NYC, she spent years focusing on delivering pinpoint radiation using the Gamma Knife where precision is of utmost importance. “Not all cancer centers are equipped with a Gamma Knife,” she says. “We have the state-of-the-art equipment, comparable to major medical centers, but our location is much more convenient for our patients.”
With the Westchester Brain Tumor Program, “You get top-notch treatment with a team approach,” she says. “I’m honored to be a part of this program.”
M.D. University of Missouri, Kansas City, Missouri
B.S. University of Missouri, Kansas City, Missouri
Postgraduate Training and Fellowships:
Chief Resident, Radiation Oncology, College of Physicians & Surgeons of Columbia University, New York, New York
Research Fellow, Radiation Oncology, College of Physicians & Surgeons of Columbia University. Work performed at Massachusetts General Hospital, Boston, Massachusetts
Resident, Radiation Oncology, College of Physicians & Surgeons of Columbia University, New York, New York
Resident, Internal Medicine, Beth Israel Medical Center, New York, New York
Connecticut State Medical License
New York State Medical License
American Board of Radiation Oncology
American Board of Internal Medicine
Clinical Experience in Advanced Technology:
Gamma Knife Stereotactic Radiosurgery
High Dose Rate Brachytherapy
Intensity Modulated Radiation Therapy
ASTRO Relief Fund Award
Golden Key Honor Society
Academic Scholarship, University of Missouri-Kansas City
Pengpeng Zhang, PhD., Ronald Brisman, MD., Julie Choi, MD., Xiang Li, PhD.
“Where to Locate the Isocenter? The Treatment Strategy for Repeat Trigeminal Neuralgia Radiosurgery.” International Journal of Radiation Oncology Biology Physics, Vol. 62, No.1: 38-93, 2005.
Choi, J.C.,Nanda, R.K., Smith D.H., Wuu, PhD., Schiff, P.B. “Potential Decreased Morbidity of Interstitial Brachytherapy for Gynecologic Malignancies Using Laparoscopy: A Pilot Study,” Gynecologic Oncology73:210-215, 1999.
Choi, J.C.,Nanda, R.K., Smith D.H., Wuu, PhD., Schiff, P.B. “Potential Decreased Morbidity of Interstitial Brachytherapy for Gynecologic Malignancies Using Laparoscopy: A Pilot Study.” American Society for Therapeutic Radiology and Oncology.OrOctober 1997. International Journal of Radiation Oncology Biology Physics, Vol. 39, No. 2 Suppl, 1997, p. 301.
Selected Invited Lectures:
Where to Place the Shot? A Treatment Strategy for Repeat Trigeminal Neuralgia Radiosurgery.12th International Meeting of the Leksell Gamma Knife Society. Vienna, Austria, May 2004
Laparoscopy Assisted Interstitial Brachytherapy for Gynecologic Malignancies:
A Pilot Study.1998 Annual Meeting of theSociety of Memorial Gynecologic Oncologists. Southampton Princess, Bermuda, October 9, 1998.
Potential Decreased Morbidity of Interstitial Brachytherapy for Gynecologic Malignancies Using Laparoscopy:A Pilot Study. 1st Annual Florence Chu Lecture. Memorial Sloan-Kettering Cancer Center, New York, NY, November 1997.
Potential Decreased Morbidity of Interstitial Brachytherapy for Gynecologic Malignancies Using Laparoscopy: A Pilot Study. Korean American Society for Therapeutic Radiology and Oncology. Orlando, FL, October 1997.